- Home
- DUKR vs RKTO Comparison
DUKR vs RKTO Comparison
Compare DUKR & RKTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$5.25
N/A
Current Price
$0.67
Company Overview
Basic Information| Metric | DUKR | RKTO |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 18.9M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DUKR | RKTO |
|---|---|---|
| Price | $5.25 | $0.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.0K | ★ 328.6K |
| Earning Date | 11-20-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.69 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $377,000.00 | N/A |
| Revenue This Year | $430.50 | N/A |
| Revenue Next Year | $245.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 249.07 | N/A |
| 52 Week Low | $4.75 | $0.62 |
| 52 Week High | $7.41 | $1.19 |
Technical Indicators
Market Signals| Indicator | DUKR | RKTO |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 40.45 |
| Support Level | $4.96 | $0.62 |
| Resistance Level | $5.93 | $0.93 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 26.32 | 8.10 |
Price Performance
Historical Comparison DUKR
RKTO
About RKTO Rocket One Inc. Common Stock
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.